Xarelto generic 2025?

When might Xarelto go generic?

The patent for Xarelto, also known as rivaroxaban, is set to expire in 2026. [1] This means that generic versions of the drug could become available after this date, potentially leading to lower costs for patients and healthcare systems.

What does patent expiry mean for Xarelto?

Patent expiry marks the end of the period during which the original manufacturer has exclusive rights to sell the drug. Once patents expire, other companies can apply to the U.S. Food and Drug Administration (FDA) to manufacture and market generic versions of the medication. [2]

Can other companies produce Xarelto before the patent expires?

While the primary patent is expected to expire in 2026, the landscape of drug patents can be complex. Legal challenges and secondary patents can sometimes influence the timeline for generic entry. DrugPatentWatch.com tracks these patent expirations and potential challenges. [1]

How does the availability of generics impact drug pricing?

Generally, the introduction of generic drugs leads to significant price reductions due to increased competition. This can make medications more accessible to a wider patient population. [2]

What is rivaroxaban?

Rivaroxaban is an anticoagulant medication used to prevent blood clots in various conditions, including atrial fibrillation, deep vein thrombosis, and pulmonary embolism. It works by inhibiting Factor Xa, a key enzyme in the blood clotting cascade. [3]

Where can I find more information on Xarelto patents and generic availability?

Information on Xarelto's patent status, including expiration dates and potential challenges, can be found on DrugPatentWatch.com. [1]

Sources:
[1] https://drugpatentwatch.com/
[2] https://www.fda.gov/
[3] https://www.rxlist.com/